Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Purdue Pharma secures permission to maintain business as bankruptcy unfolds

      Purdue Pharma secures permission to maintain business as bankruptcy unfolds

      Medical Dialogues Bureau18 Sept 2019 9:00 AM IST
      Purdue lawyers secured permission on Tuesday for the company to maintain business as usual. That includes paying employees and vendors, supplying...
      Glenmark bags USFDA orphan drug status for antibody GBR 1342 to treat multiple myeloma

      Glenmark bags USFDA orphan drug status for antibody GBR 1342 to treat multiple myeloma

      Medical Dialogues Bureau17 Sept 2019 4:14 PM IST
      Derived from the company's proprietary BEAT (Bispecific Engagement by Antibodies based on the T cell receptor) technology, GBR 1342 is being...
      Cipla, Stempeutics ink licensing deal for Stempeucel-DFU to treat diabetic foot ulcer

      Cipla, Stempeutics ink licensing deal for Stempeucel-DFU to treat diabetic foot ulcer

      Medical Dialogues Bureau17 Sept 2019 1:17 PM IST
      Under the agreement, Cipla will get exclusive marketing rights for five years in India for the diabetic foot ulcer (DFU) product. Stempeutics will...
      Dr Reddys unveils OTC store-brand equivalent of Prevacid 24HR Capsules in US to treat heartburn

      Dr Reddys unveils OTC store-brand equivalent of Prevacid 24HR Capsules in US to treat heartburn

      Medical Dialogues Bureau17 Sept 2019 1:06 PM IST
      Dr Reddy’s OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, is an over-the-counter, Proton Pump Inhibitor (PPI) used to treat frequent heartburn...
      Job Alert: NIPER Hyderabad releases vacancies for Faculty Post, Details

      Job Alert: NIPER Hyderabad releases vacancies for Faculty Post, Details

      Medical Dialogues Bureau17 Sept 2019 9:30 AM IST
      Hyderabad: National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad has released 18 vacancies for Faculty Post on Regular...
      Roche gets USFDA clearance for cobas pro solutions for diagnostics labs

      Roche gets USFDA clearance for cobas pro solutions for diagnostics labs

      Medical Dialogues Bureau17 Sept 2019 9:15 AM IST
      With the cobas pro integrated solutions, laboratories are now able to run tests faster on less equipment, automate manual tasks and deliver results...
      Novartis Cosentyx meets primary endpoint in patients with axial spondyloarthritis

      Novartis Cosentyx meets primary endpoint in patients with axial spondyloarthritis

      Medical Dialogues Bureau17 Sept 2019 9:00 AM IST
      Novartis Cosentyx is backed by clinical evidence, including 5-year data across three indications of psoriasis, PsA and AS as well as data from...
      Cadila Pharma bags ObserveNow Future of Workplace Award among 50 others in fray

      Cadila Pharma bags ObserveNow Future of Workplace Award among 50 others in fray

      Medical Dialogues Bureau16 Sept 2019 9:25 AM IST
      "The selection was made on the basis of the technologies used in the company, HR policies, and initiatives taken to make the organization an...
      Biogen Alzheimer drug Aducanumab failure wipes USD 18 billion from market value

      Biogen Alzheimer drug Aducanumab failure wipes USD 18 billion from market value

      Medical Dialogues Bureau16 Sept 2019 9:00 AM IST
      Aducanumab's failure wiped out more than $18 billion of Biogen Inc's market value, as investors were betting on the treatment to buoy the drugmaker,...
      Purdue Pharma files for bankruptcy protection as part of opioid settlement

      Purdue Pharma files for bankruptcy protection as part of opioid settlement

      Medical Dialogues Bureau16 Sept 2019 8:59 AM IST
      Purdue Pharma's board met on Sunday evening to approve the long-expected bankruptcy filing, which the company is pursuing to restructure under terms...
      Unichem Labs receives zero USFDA observations for Roha facility

      Unichem Labs receives zero USFDA observations for Roha facility

      Medical Dialogues Bureau15 Sept 2019 10:00 AM IST
      The inspection of the active pharmaceutical ingredients facility at Roha was conducted from September 9 to September 12 2019 by the United States Food...
      GSK gets USFDA nod for Nucala, only biologic to treat eosinophilic asthma in age group 6-11 year

      GSK gets USFDA nod for Nucala, only biologic to treat eosinophilic asthma in age group 6-11 year

      Medical Dialogues Bureau15 Sept 2019 9:50 AM IST
      Nucala is the only targeted biologic to be approved for the condition in the six to 11-year age group in the US, said GSK.New Delhi: GlaxoSmithKline...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok